Mycobacterium tuberculosis infection of end-stage renal disease patients in Taiwan: a nationwide longitudinal study S.-Y. Li, T.-J. Chen, K.-W. Chung, L.-W. Tsai, W.-C. Yang, J.-Y. Chen, T.-W. Chen Clinical Microbiology and Infection Volume 17, Issue 11, Pages 1646-1652 (November 2011) DOI: 10.1111/j.1469-0691.2011.03473.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Patient selection flow chart. ESRD, end-stage renal disease; MTB, Mycobacterium tuberculosis; RRT, renal replacement therapy. Clinical Microbiology and Infection 2011 17, 1646-1652DOI: (10.1111/j.1469-0691.2011.03473.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 2 Kaplan–Meier plots of the risk factors for Mycobacterium tuberculosis (MTB) infection among end-stage renal disease (ESRD) patients. Kaplan–Meier plots of cumulative MTB infection rate among ESRD patients, stratified by gender (a), age (b), hyperlipidaemia (c), hypertension (d), chronic obstructive pulmonary disease (COPD) (e), silicosis (f), monthly salary (g), and renal replacement modality (h). HD, haemodialysis; PD, peritoneal dialysis. Clinical Microbiology and Infection 2011 17, 1646-1652DOI: (10.1111/j.1469-0691.2011.03473.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions